Outcomes of in vitro fertilization as a multifactorial clinical problem or reproductive medicine
https://doi.org/10.21518/2079-701X-2015-9-84-91
Abstract
The study was conducted during the years 2013--2014 by the assisted reproductive technology (ART) department of the Moscow Regional Perinatal Center in Balashikha. We analyzed 384 IVF and ET cases using clinical and embryological criteria. It was found that the outcome of induced pregnancy is associated with such factors as patient age, body mass index, polycystic ovary syndrome, hyperandrogenism, congenital thrombophilia, endometrial pathology, miscarriage history, total dose of HT per COS cycle, number of best quality embryos in ovarian cohort, level of serum hCG on day 14 after embryo transfer. "Best quality embryo in ovarian cohort" factor is of great interest due to high reliability and few studies in this area. Quality distribution of embryos does not occur randomly or as part of an isolated in vitro process; it follows a certain pattern that directly affects the outcome of pregnancy.
About the Authors
E. B. Rudakova
Moscow Regional Perinatal Center, Moscow region, Balashikha
Russian Federation
Russian Federation
L. Y. Zamakhovskaya
Moscow Regional Perinatal Center, Moscow region, Balashikha
Russian Federation
Russian Federation
T. V. Strizhova
Moscow Regional Perinatal Center, Moscow region, Balashikha
Russian Federation
Russian Federation
O. B. Trubnikova
Moscow Regional Perinatal Center, Moscow region, Balashikha
Russian Federation
Russian Federation
L. V. Tatarinova
Moscow Regional Perinatal Center, Moscow region, Balashikha
Russian Federation
Russian Federation
References
1. Кулаков В.И., Прилепская В.Н., Радзинский В.Е. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии. М.: ГЭОТАР-Медиа, 2007. 1056 с.
2. Невынашивание беременности: патогенез, диагностика, лечение. Клиническое руководство. Под ред. Стрижакова А.Н., Давыдова А.И., Игнатенко И.В., Белоцерковцевой ЛД. 2011: 69.
3. Гинекология. Сильвия К. Роузвиа; пер. с англ.; под общ. ред. акад. РАМН Э.К. Айламазяна. 2-е изд. М.: МЕДпресс-информ, 2007. 520 с.: ил.
4. DeLvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update. 2002. 8: 559-577.
5. Olivennes F, Frydman R. Friendly IVF: the way of the future? Hum. Reprod. 1998. 13: 1121-1214.
6. EN ISO 11608-1:2000. Pen-injectors for medical use - Part 1: Pen-injectors - Requirements and test methods.
7. Руководство по клинической эмбриологии: сделано в МЦРМ. [В.С. Корсак и др.]; под ред. В.С. Корсака. М.: МК, 2011. 224 с.
8. Боярский К.Ю., Василевская С.Е. Цитогенетический анализ ооцитов, полученных у старшей возрастной группы в программе ЭКО. Проблемы репродукции 1998; 4: 2: 34-36.
9. Fuji Y, Ozaki K, Yamamasu S et al. DNA fragmentation of oocytes in aged mice. Hum Reprod 1996; 11: 1480-83.
10. Wood C. Calderon I, Crombie A. Age and fertility: result of assisted reproductive technology in women over 40 years. J.Assist. Reprod. Genet. 1992. 9. 482.
11. Tian L, Shen H, Lu O, Norman RJ, Wang J. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab 2007; 92: 1430-1433.
12. De Bruin JP, Dorland M, Spek ER et al. Ultrastructure of the resting ovarian follicle pool in healthy young women. Biol. Reprod. 2002. 66. 1151-1160.
13. Назаренко Т.А., Смирнова А.А. Индукция моно- и суперовуляции. Оценка овариального резерва, ультразвуковой и гормональный мониторинг. Проблемы репродукции. 2004. 1. 36-42.
14. Kawamura K, Sato N, Fukuda J, Kodama H, Kumagai J, Tanikawa H,Murata M, Tanaka T. The role of leptin during the development ofmouse preimplantation embryos. Mol Cell Endocrinol 2003; 202: 185-189.
15. Landres IV, Milki AA, Lathi RB. Karyotype of miscarriages in relation to maternal weight. Hum Reprod 2010; 25: 1123-1126.
16. Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistancein women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78: 487-490.
17. Доброхотова Ю.Э. Невынашивание беременности. Инфекционные факторы. М.: «Адаманть», 2011. 9.
18. Дедов И.И., Андреева Е.Н., Пищулин А.А. Синдром гиперандрогении у женщин. Патогенез, клинические формы, дифференциальная диагностика и лечение. РАМН ГУЭНЦ, 2006: 9-11.
19. Бакотина И.В. Клинико-морфологические особенности формирования хориона у пациенток с неразвивающейся беременностью. Автореф. дисс. канд. мед. наук. М., 2005. 26.
20. Sagle M, Bishop K, Ridley N. Recurrent early miscarriage and polycystic ovaries. BMJ.1988. 297. 1027-1028.
Review
For citations:
Rudakova EB, Zamakhovskaya LY, Strizhova TV, Trubnikova OB, Tatarinova LV. Outcomes of in vitro fertilization as a multifactorial clinical problem or reproductive medicine. Meditsinskiy sovet = Medical Council. 2015;(9):84-91. (In Russ.) https://doi.org/10.21518/2079-701X-2015-9-84-91
Views:
708
Email this article 